Tuesday, September 22, 2026
8:30 AM – 9:30 AM PDT
11:30 AM – 12:30 PM EDT
5:30 PM – 6:30 PM CEST
The format of the webinar will be a panel discussion.
Learning Objectives:
-
Understand financial toxicity in cancer care and its impact on both patients and healthcare systems
-
Highlight the discrepancies between countries and the current financial burden related to crisis
-
Define the impact of biosimilars in reducing financial burden to the healthcare system
-
Give a multidisciplinary perspective shared between people involved in drug access
-
Understand the impact on treatment availability and health system sustainability
-
Understand how biosimilars can shape access to care over the next 10–15 years
Speakers:
Prof. Florian Scotté
(Chair)
Dr. Elad Sharon
Dr. Mapi Fleury
Dr. Tourane Corbière
(Patient Partner)
Dr. Sreedhar Sagi
This webinar is made possible by sponsorship provided by Sandoz
